Conversations with Tyler

Tyler Cowen engages today’s deepest thinkers in wide-ranging explorations of their work, the world, and everything in between. New conversations every other Wednesday. Subscribe wherever you get your podcasts.

https://www.conversationswithtyler.com

Eine durchschnittliche Folge dieses Podcasts dauert 57m. Bisher sind 223 Folge(n) erschienen. Alle zwei Wochen gibt es eine neue Folge dieses Podcasts.

Gesamtlänge aller Episoden: 9 days 9 hours 27 minutes

subscribe
share






episode 130: Zeynep Tufekci on the Sociology of The Moment (Live)


The problems COVID-19 revealed in our institutions—and how to fix them.


share








 August 25, 2021  1h5m
 
 

episode 129: Andrew Sullivan on Braving New Intellectual Journeys


Why are so few intellectuals comfortable with life out on a limb?


share








 August 11, 2021  55m
 
 

episode 128: Niall Ferguson on Why We Study History


We don’t study the past for its own sake.


share








 July 28, 2021  54m
 
 

episode 127: Alexander the Grate on Life as an NFA


Why none of us can escape shelter insecurity.


share








 July 14, 2021  44m
 
 

episode 126: Richard Prum on Birds, Beauty, and Finding Your Own Way


How ecology and selection drive avian evolution.


share








 June 30, 2021  50m
 
 

episode 125: Elijah Millgram on the Philosophical Life


Why personal experience is underrated.


share








 June 16, 2021  1h8m
 
 

episode 124: David Deutsch on Multiple Worlds and Our Place in Them


Plus, the defining human attribute visible from galaxies far, far away.


share








 June 2, 2021  1h1m
 
 

episode 123: Mark Carney on Central Banking and Shared Values


How shared objectives can flip risks into value creation.


share








 May 26, 2021  54m
 
 

episode 122: Pierpaolo Barbieri on Latin American FinTech


Meet the startup founder disrupting the banking industry in Argentina and Mexico


share








 May 19, 2021  56m
 
 

episode 121: Daniel Carpenter on Smart Regulation


The leading expert on the FDA discusses policy in the time of COVID-19.


share








 May 5, 2021  1h8m